Share-based Compensation - Restrictive stock awards (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Mar. 08, 2021 |
Feb. 17, 2020 |
Feb. 29, 2020 |
Mar. 31, 2021 |
Mar. 31, 2020 |
Dec. 31, 2020 |
|
| Number of Units | ||||||
| Granted | 7,311,904 | |||||
| Exercised and converted to common shares | (5,928,571) | |||||
| Outstanding | 1,383,333 | 1,383,333 | ||||
| Exercisable | 691,666 | |||||
| Weighted Average Grant Date Fair Value | ||||||
| Granted | $ 0.023 | |||||
| Exercised and converted to common shares | 0.014 | |||||
| Outstanding | $ 0.060 | $ 0.060 | ||||
| Exercisable | $ 0.060 | |||||
| Restricted stock award | ||||||
| Weighted Average Grant Date Fair Value | ||||||
| Value of awards | $ 5,928,571 | $ 83,000 | ||||
| Closing stock price | $ 0.014 | |||||
| Stock-based compensation expense | $ 21,000 | $ 27,000 | ||||
| Mr. Levy | Restricted stock award | ||||||
| Weighted Average Grant Date Fair Value | ||||||
| Value of awards | $ 1,383,333 | |||||
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are exercisable as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards exercised during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of exercisable award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|